| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Bassler Bonnie L is a Director at RPRX, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 26 sales. Those positions are worth an estimated $6.0M at current prices.
Our model assigns Bassler Bonnie L a middling insider score of 59/100, based on 22 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of +4.5%.
Bassler Bonnie L's largest disclosed position is in RPRX as Director, worth about $4.7M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 853 | $829.00 | $707,137.00 | -40.6% | -5.1% | +41.2% | |
| Aug 10, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 853 | $789.00 | $673,017.00 | -40.6% | +3.8% | +42.7% | |
| Mar 24, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,240 | $818.00 | $1,014,320.00 | -49.9% | -4.9% | +18.0% | |
| Feb 3, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,021 | $779.00 | $795,359.00 | -45.0% | -3.7% | +20.7% | |
| Dec 8, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 218 | $779.00 | $169,822.00 | -16.8% | -2.6% | +9.8% | |
| Sep 9, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 3,167 | $704.65 | $2,231,624.21 | -74.5% | +5.7% | +14.7% | |
| Apr 7, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,240 | $725.00 | $899,000.00 | -53.4% | -17.6% | +14.8% | |
| Mar 30, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,240 | $700.00 | $868,000.00 | -53.4% | -14.1% | +17.2% | |
| Aug 16, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,219 | $630.00 | $767,970.00 | -57.8% | +3.0% | +3.2% | |
| Aug 5, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 2,559 | $600.00 | $1,535,400.00 | -74.2% | +8.2% | +1.8% |